The effect of hydrogen-rich water consumption on premenstrual symptoms and quality of life: a randomized controlled trial.
Menekşe Nazlı Aker, İlknur M Gönenç, Dilan Çalişici, Menekşe Bulut, Duried Alwazeer, Tyler W LeBaron · BMC women's health · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This human study examined the effect of drinking HRW on the severity of premenstrual symptoms and the quality of life of women who suffer from PMS. These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in Participants were randomized into two groups (intervention group=33, control group=32) using the block randomization method.
What the Researchers Studied
The researchers studied Participants were randomized into two groups (intervention group=33, control group=32) using the block randomization method. The study used a randomized, placebo-controlled human clinical trial. The comparison condition was placebo.
What Effects Did Molecular Hydrogen Have?
2000 mL hydrogen-rich water per reported dose; dissolved H₂ concentration was not reported in the available source text, so H2HUBB did not estimate milligrams of H₂. Hydrogen-rich water (HRW) has antioxidant and anti-inflammatory properties that may treat PMS.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a randomized, placebo-controlled human clinical trial. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was Participants were randomized into two groups (intervention group=33, control group=32) using the block randomization method. The study used a randomized, placebo-controlled human clinical trial. The hydrogen delivery method was hydrogen-rich water. H2HUBB translates the reported hydrogen dose as 2000 mL hydrogen-rich water per reported dose; dissolved H₂ concentration was not reported in the available source text, so H2HUBB did not estimate milligrams of H₂.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.